TAKHZYRO
TAKHZYRO
Approved
DIN Number
02505614
Drug Class
Human
Market Date
Jan 18, 2021
Company
HC
takeda canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02505614
AIG Number0160670001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
B06AC05 LANADELUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification92:32.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
LANADELUMABActive
Strength: 300 MG / 2 ML
Monograph: LANADELUMAB